Breaking News - The Fly

Open Search

RNXT

RenovoRx

$

()

RenovoRx files to sell 6.13M shares of common stock for holders

RNXT

4/19/2024 - 17:03pm

RenovoRx regains compliance with Nasdaq stockholders' equity requirement

RNXT

4/18/2024 - 08:42am

RenovoRx price target lowered by 50c at Alliance Global Partners, here's why

RNXT

4/15/2024 - 10:39am

RenovoRx to present initial interim analysis of Phase III TIGeR-PaC trial

RNXT

4/5/2024 - 08:31am

RenovoRx promotes Leesa Gentry to chief clinical officer

RNXT

3/8/2024 - 16:07pm

RenovoRx sees 2nd interim analysis on Phase III TIGeR-PaC by 2024-end

RNXT

2/6/2024 - 08:45am

Macy's upgraded, New York Community downgraded: Wall Street's top analyst calls

M , NYCB , RDW

…

2/2/2024 - 09:37am

RenovoRx initiated with bullish view at Alliance Global Partners, here's why

RNXT

2/2/2024 - 07:02am

RenovoRx engages Oklahoma University as clinical site for CouGar trial

RNXT

12/21/2023 - 08:50am

RenovoRx files international IP app for TAMP platform and IP delivery system

RNXT

12/13/2023 - 08:48am

RenovoRx price target lowered to $7 from $13 at Roth MKM

RNXT

11/15/2023 - 08:12am

RenovoRx downgraded to Hold from Buy at Maxim

RNXT

11/15/2023 - 07:19am

RenovoRx, Imugene announce oncolytic virus therapy collaboration, using TAMP

RNXT

7/20/2023 - 08:07am

RenovoRx: RenovoGem delays cancer progression in LAPC

RNXT

6/29/2023 - 08:11am

RenovoRx participates in a conference call with Roth MKM

RNXT

6/15/2023 - 04:55am